Navigation Links
Patheon to Present at 2013 DCAT Week
Date:3/6/2013

(PRWEB) March 06, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that the company will present at Drug, Chemical and Associated Technologies Association (DCAT) week in New York City, NY.

A presentation “Key Trends for Sterile Injectable Manufacturing and Outsourcing” will be given by Tony Pidgeon, Senior Manager, Global Science and Technology, Patheon Inc. on Wednesday, March 13, 2013 at 9 a.m. Eastern Time. The discussion will focus on trends and steps that are being taken by contract manufacturing organizations, as well as branded and generic pharmaceutical companies, to improve operational security while retaining competitiveness. Visit http://www.patheon.com for more information.

Patheon executives will also be available to meet during DCAT week from March 11-14, 2013. To schedule a meeting in advance send an email to events(at)patheon(dot)com.    

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10495185.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon Exhibits at the 2013 Biopharmaceutical Development and Production Week
2. Patheon to Present at Informex USA
3. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
4. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
5. Dyadic International To Present At World Biofuels Markets
6. BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
7. Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
8. P&G Beauty & Grooming to present advancements in skin aging & stress sweat at AAD Meeting
9. Lexicon To Present At The Cowen Healthcare Conference
10. Assemblyman Levine Presents Resolution Recognizing Rare Disease Day at Capitol
11. QualityStar Presenting at Biomarkers & Diagnostics World Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... report analyzes the worldwide markets for Biostimulants in US$ by ... Extract Based, and Others. The report also analyzes the Global ... Crops, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided for the ...
(Date:12/8/2016)... -- AskLinkerReports.com has published a report on Amyloglucosidase ... 2016 Market Research Report. From a basic outline of the ... all covered in the report. This report projects investment feasibility ... the Amyloglucosidase industry. ... , Complete report ...
(Date:12/8/2016)... UK (PRWEB) , ... December 08, 2016 , ... ... precision light to control cells — optogenetics — is key to exciting advances ... of the art, spatially patterned light projected via free-space optics stimulates small, transparent ...
(Date:12/8/2016)... Spain , Dec. 8, 2016  Anaconda BioMed ... the development of the next generation neuro-thrombectomy system for ... appointment of Tudor G. Jovin, MD to join its ... serve as a strategic network of scientific and clinical ... the development of the ANCD BRAIN ® to ...
Breaking Biology Technology:
(Date:12/6/2016)... Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today ... principal amount of its 1.414% senior unsecured notes due 2022 ... notes due 2026. The closing of the ... the satisfaction of customary closing conditions.  The notes will pay ... The Company intends to use the net proceeds from the ...
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
Breaking Biology News(10 mins):